mTOR inhibitors must be used with caution in patients with poorly controlled diabetes, hyperlipidemia, or severe pulmonary disease due to risks of metabolic abnormalities and pneumonitis [25]. The gene discussed is MTOR; the disease is diabetes mellitus.